Clinical and Molecular Epidemiology of Carbapenem-Resistant Enterobacteriaceae Among Adult Inpatients in Singapore.

Background Since 2010, the incidence of carbapenem-resistant Enterobacteriaceae (CRE) has been increasing in Singapore. We analyzed the clinical and molecular epidemiology of CRE among adult inpatients in Singapore. Methods Quarterly incidence of unique subjects (per 100000 patient-days) with positive clinical and surveillance cultures for CRE were estimated based on mandatory data submitted to the National Public Health Laboratory by public hospitals between 2010 and 2015. CRE-positive adult inpatients were prospectively recruited from 6 public sector hospitals between December 2013 and April 2015. Subjects answered a standardized epidemiologic questionnaire and provided samples for this study. Further clinical information was extracted from subjects' electronic medical records. Whole-genome sequencing was performed on study isolates to determine transmission clusters. Results Incidence of CRE clinical cultures among adult inpatients plateaued from 2013 (range: 7.73 to 10.32 per 100000 patient-days) following an initial increase between 2010 and end-2012. We prospectively recruited 249 subjects. Their median age was 65 years, 108 (43%) were female, and 161 (64.7%) had carbapenemase-producing Enterobacteriaceae (CPE). On multivariate analysis, prior carbapenem exposure (OR: 3.23; 95% CI: 1.67-6.25) and hematological malignancies (OR: 2.85; 95% CI: 1.10-7.41) were associated with non-carbapenemase-producing CRE (NCPE) (n = 88) compared with CPE (n = 161) subjects. Among 430 CRE isolates from the 249 subjects, 307(71.3%) were CPE, of which 154(50.2%) were blaKPC-positive, 97(31.6%) blaNDM-positive, and 42 (13.7%) blaOXA-positive. Klebsiella pneumoniae (n = 180, 41.9%), Escherichia coli (n = 129, 30.0%) and Enterobacter cloacae (n = 62, 14.4%) were the main Enterobacteriaceae species. WGS (n = 206) revealed diverse bacterial strain type (STs). The predominant blaKPC-positive plasmid was pHS102707 (n = 62, 55.4%) and the predominant blaNDM-positive plasmid was pNDM-ECS01 (n = 46, 48.9%). Five transmission clusters involving 13 subjects were detected. Conclusions Clinical CRE trend among adult inpatients showed stabilization following a rapid rise since introduction in 2010 potentially due to infection prevention measures and antimicrobial stewardship. More work is needed on understanding CPE transmission dynamics.

[1]  R. Lynfield,et al.  Epidemiology of Carbapenem-Resistant Enterobacteriaceae in 7 US Communities, 2012-2013. , 2015, JAMA.

[2]  P. Nordmann,et al.  OXA-48-like carbapenemases: the phantom menace. , 2012, The Journal of antimicrobial chemotherapy.

[3]  Gopi Patel,et al.  Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Infection and the Impact of Antimicrobial and Adjunctive Therapies , 2008, Infection Control & Hospital Epidemiology.

[4]  A. Carattoli,et al.  Patient risk factors for outer membrane permeability and KPC-producing carbapenem-resistant Klebsiella pneumoniae isolation: results of a double case–control study , 2013, Infection.

[5]  N. Woodford,et al.  KPC enzymes in the UK: an analysis of the first 160 cases outside the North-West region. , 2016, The Journal of antimicrobial chemotherapy.

[6]  I. Kassis,et al.  Carbapenem Resistance Among Klebsiella pneumoniae Isolates Risk Factors, Molecular Characteristics, and Susceptibility Patterns , 2009, Infection Control & Hospital Epidemiology.

[7]  Y. Carmeli,et al.  An ongoing national intervention to contain the spread of carbapenem-resistant enterobacteriaceae. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  N. Woodford,et al.  Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study , 2010, The Lancet. Infectious diseases.

[9]  Yehuda Carmeli,et al.  Predictors of Carbapenem-Resistant Klebsiella pneumoniae Acquisition among Hospitalized Adults and Effect of Acquisition on Mortality , 2007, Antimicrobial Agents and Chemotherapy.

[10]  Evangelos I. Kritsotakis,et al.  Antibiotic use and the risk of carbapenem-resistant extended-spectrum-{beta}-lactamase-producing Klebsiella pneumoniae infection in hospitalized patients: results of a double case-control study. , 2011, The Journal of antimicrobial chemotherapy.

[11]  Kim F. Wong,et al.  Vital Signs: Estimated Effects of a Coordinated Approach for Action to Reduce Antibiotic-Resistant Infections in Health Care Facilities — United States , 2015, MMWR. Morbidity and mortality weekly report.

[12]  Fotini C Chelvatzoglou,et al.  Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case control study. , 2007, The Journal of antimicrobial chemotherapy.

[13]  N. Woodford,et al.  Carbapenem-hydrolysing IMP-1 β-lactamase in Klebsiella pneumoniae from Singapore , 1999, The Lancet.

[14]  Hui Wang,et al.  Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. , 2013, The Lancet. Infectious diseases.

[15]  Jia Jun Lee,et al.  Tracking inter-institutional spread of NDM and identification of a novel NDM-positive plasmid, pSg1-NDM, using next-generation sequencing approaches. , 2016, The Journal of antimicrobial chemotherapy.

[16]  P. Nordmann,et al.  The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[17]  R. Lin,et al.  Klebsiella pneumoniae Carbapenemase-producing Enterobacteria in Hospital, Singapore , 2012, Emerging infectious diseases.

[18]  S. Choi,et al.  Risk factors for the acquisition of carbapenem-resistant Klebsiella pneumoniae among hospitalized patients. , 2005, Microbial drug resistance.

[19]  S. Choi,et al.  Risk factors for the acquisition of carbapenem-resistant Escherichia coli among hospitalized patients. , 2006, Diagnostic microbiology and infectious disease.

[20]  Y. Carmeli,et al.  Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance: a systematic review. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  P. Harris,et al.  Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support , 2009, J. Biomed. Informatics.

[22]  R. Jureen,et al.  OXA-181-producing Klebsiella pneumoniae establishing in Singapore , 2013, BMC Infectious Diseases.

[23]  R. Lin,et al.  Molecular characterization of NDM-1 producing Enterobacteriaceae isolates in Singapore hospitals. , 2012, Western Pacific surveillance and response journal : WPSAR.